1 tracked superinvestor hold INHIBRX BIOSCIENCES INC (INBX), worth $106M combined, led by Andreas Halvorsen. Smart money is trimming INBX as of the latest 13F filings.
Current price
$121.17
+337.1%
1Y
Inhibrx Biosciences, Inc. is a clinical-stage biopharmaceutical company, which includes a pipeline of novel biologic therapeutic candidates, developed using proprietary modular protein engineering platforms. Its clinical pipeline of therapeutic candidates includes INBRX-109 and INBRX-106, both of which utilize multivalent formats where the precise valency can be optimized in a target-centric way…
Market cap
$1.9B
P/E
-14.25
Div yield
0.0%
Revenue YoY
550.0%
Analyst target
$285
Snapshot for context. For deep analysis use a stock screener — this page is about who owns it.
Superinvestors holding
1
tracked 13F / N-PORT funds
Combined value
$106M
disclosed long exposure
Tier-1 conviction
1
concentrated holders
Net this quarter
-1
0 buying · 1 selling
Smart money is net reducing INBX: 1 funds trimmed versus 0 adding.
INHIBRX BIOSCIENCES INC (INBX) is held by 1 tracked funds worth $106M combined, 1 of them concentrated Tier-1 managers whose positions carry real conviction.
The largest position belongs to Andreas Halvorsen at 0.3% of their book — no single tracked manager treats it as an outsized, top-weighted bet.
No tracked fund opened a new position this quarter; 0 added and 1 trimmed, a net reduction.
| Investor | Move | % of their portfolio | Position value |
|---|---|---|---|
| Trimmed | 0.3% | $106M |
Tier badge = signal quality: 1 concentrated conviction · 2 quant/multi (context) · 3 retail & diversified. Only Tier 1 holdings feed the consensus signal.
Which superinvestors own INBX?
1 tracked funds hold INHIBRX BIOSCIENCES INC (INBX), the largest being Andreas Halvorsen (Viking Global Investors) at 0.3% of its 13F portfolio. 1 of them are concentrated Tier-1 conviction managers.
Is smart money buying or selling INBX?
In the most recent 13F quarter, 0 tracked funds added or opened INBX and 1 trimmed it.
How much INBX do tracked funds hold?
Combined disclosed long exposure to INBX across tracked superinvestors is $106M as of the Jun 2026 filings.
One email when a tracked manager opens, adds to or files to sell a position — from Form 4, 13D and Form 144, not the 45-day-old 13F.
Holdings aggregated from the latest SEC 13F & N-PORT filings via FMP · Jun 2026 quarter. Long equity positions only, reported with up to a 45-day delay — for activity between filings see real-time moves. Not financial advice.